← Eichor
Study identifier: NCT06495073 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Determining the MCID for the TOPICS-SF and PROMIS-10 in Older Patients That Suffered an Ischemic Stroke or TIA

Condition: Ischemic Stroke · TIA  ·  Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

PhaseN/A
Planned participants125
Who can joinAll sexes, 70 Years to 120 Years
Healthy volunteersNo

About this study

Patient-related outcome measures (PROMs) play a crucial role in assessing patient outcomes in healthcare. Two of these PROMs are the The Older Persons and Informal Caregivers Survey Short Form (TOPICS-SF) and Patient-Reported Outcomes Measurement Information System Global Health Short Form (PROMIS-10). The investigators aim to determine the Minimal Clinically Important Difference (MCID) for the TOPICS-SF and PROMIS-10 in older people that suffered an ischemic stroke or Transient Ischemic Attack (TIA), using an anchor-based method.

This description comes directly from the study's public registry record.

Talk to the study team

Susanna R Prins, MSc  ·  0031 20 566 9111  ·  s.r.prins@amsterdamumc.nl

Birgit A Damoiseaux-Volman,, PhD  ·  0031 20 566 9111  ·  b.a.damoiseaux@amsterdamumc.nl

Always discuss trial participation with your own doctor first.

Locations (2)

OLVG, locatie WestAmsterdam, North Holland, NetherlandsNot Yet Recruiting
Amsterdam UMC, locatie AMCAmsterdam, North Holland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06495073